Prostate Cancer Incidence and Mortality
Global Status and Temporal Trends in 89 Countries From 2000 to 2019
Bibliographic Data
| ID | 22072777 |
|---|---|
| Authors | Le Wang (0000-0003-0327-7315, Zhejiang Cancer Hospital), Bin Lu (0000-0001-7847-7560, Chinese Academy of Medical Sciences & Peking Union Medical College), Mengjie He (0000-0002-5542-8149, Zhejiang Center for Disease Control and Prevention), Youqing Wang (0000-0002-1408-7667, Zhejiang Cancer Hospital), Zongping Wang (0000-0003-3529-5657, Zhejiang Cancer Hospital, corresponding author), Lingbin Du (0000-0002-1992-7784, Zhejiang Cancer Hospital, corresponding author) |
| Year | 2022 |
| Volume | 10 |
| Pages | 811044-811044 |
| Publication date | 2022-02-16 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.811044 |
| PMID | 35252092 |
| OpenAlex | W4213089453 |
| Language | EN |
| Citations received | 12 |
| References cited | 59 |
AIMS: To evaluate current status of prostate cancer incidence and mortality worldwide, and compare the global trends of incidence and mortality in the past two decades and in the most recent period. METHODS: Data on the incidence and mortality of prostate cancer for 174 countries in 2020 were obtained from the GLOBOCAN 2020 database, and associations with the human development index (HDI) were evaluated. Data for trend analyses in 89 countries from 2000 to 2019 were retrieved from the Global Burden of Disease 2019 platform. Age standardized incidence rate (ASIR) and mortality rate (ASMR) were calculated by using the Segi's population. The average annual percent changes (AAPC) of ASIRs and ASMRs were evaluated by joinpoint regression analysis. RESULTS: < 0.001). In the past two decades, ASIRs have been increasing in 65 countries, stable in 15 countries and decreasing in 9 countries, and ASMRs have been increasing in 19 countries, stable in 25 countries and decreasing in 45 countries, respectively. In the most recent period, 44 countries have increasing ASIRs, and 32 countries have decreasing ASMRs, respectively. For instance, in the United States of America, the AAPC of ASIRs significantly decreased by 0.62% and ASMRs significantly decreased by 1.22% from 2000 to 2019, while the AAPC from 2015 to 2019 significantly increased by 0.49% for ASIRs and significantly increased by 0.48% for ASMRs. CONCLUSION: The magnitude of increasing incidence and decreasing mortality of prostate cancer is attenuated in the recent period. Further study is needed to analyze the absolute effect of risk factors, PSA screening and treatment
Cancer · Disease burden · Economic growth · Environmental health · Global health · Human Development Index · Mortality rate · Pathology · Population · Prostate cancer · Public health · Demography · Global Cancer Incidence and Screening · Medicine · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research · Internal Medicine
Risk of prostate cancer associated with long-term air pollution exposure
Prostate Cancer Knowledge, Beliefs and Screening Uptake among Black Survivors
Temporal trends and regional disparities in prostate cancer mortality in the United States, 1999–2023
Relationship between universal health insurance benefits and prostate cancer mortality in Colombia
Strategies to Reduce the Burden of Prostate Cancer and Their Acceptability in Africa
Psychosocial experiences of prostate cancer survivors after treatment
Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019
Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors
The global, regional, and national prostate cancer burden and trends from 1990 to 2021, results from the global burden of disease study 2021
Racial disparities in the receipt of therapies for cancer, hypertension, and diabetes, and in mortality in a large population-based cohort of older men with prostate cancer
Time trends in the incidence of cancer in the state of Mato Grosso, Brazil, from 2001 to 2016
Tendências temporais na incidência de câncer no estado de Mato Grosso, Brasil, de 2001 a 2016
Permutation tests for joinpoint regression with applications to cancer rates
Health policy and public health implications of obesity in China
Global surveillance of trends in cancer survival 2000–14 (Concord-3)
Global Cancer Statistics 2020
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
| Unique citing works | 12 |
|---|---|
| Citations per year | 3 |
| Citation span | 2022 - 2026 (5) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 12 |